Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 73, Issue 6
An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letter
An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis
Online download statistics by month:
Online download statistics by month: February 2014 to March 2024
Abstract
Full
Pdf
Feb 2014
442
81
105
Mar 2014
53
17
60
Apr 2014
96
11
19
May 2014
345
110
77
Jun 2014
88
46
24
Jul 2014
58
17
18
Aug 2014
29
12
17
Sep 2014
48
15
18
Oct 2014
30
12
9
Nov 2014
66
7
13
Dec 2014
26
23
21
Jan 2015
30
8
4
Feb 2015
14
5
5
Mar 2015
30
12
13
Apr 2015
17
13
7
May 2015
37
8
9
Jun 2015
15
7
4
Jul 2015
20
2
4
Aug 2015
12
3
4
Sep 2015
32
12
8
Oct 2015
9
1
0
Nov 2015
33
5
5
Dec 2015
28
9
7
Jan 2016
25
22
16
Feb 2016
12
5
4
Mar 2016
12
9
9
Apr 2016
19
7
5
May 2016
23
3
1
Jun 2016
29
7
18
Jul 2016
11
5
2
Aug 2016
21
3
1
Sep 2016
38
7
11
Oct 2016
26
4
10
Nov 2016
22
4
3
Dec 2016
21
2
4
Jan 2017
28
5
2
Feb 2017
29
12
9
Mar 2017
44
20
11
Apr 2017
29
5
8
May 2017
31
3
2
Jun 2017
34
3
10
Jul 2017
42
1
2
Aug 2017
58
2
4
Sep 2017
72
7
5
Oct 2017
79
7
7
Nov 2017
88
9
12
Dec 2017
81
5
7
Jan 2018
104
0
7
Feb 2018
36
1
4
Mar 2018
65
4
1
Apr 2018
57
7
2
May 2018
55
1
1
Jun 2018
40
0
0
Jul 2018
26
3
4
Aug 2018
53
1
3
Sep 2018
54
8
3
Oct 2018
58
3
4
Nov 2018
41
4
4
Dec 2018
56
3
3
Jan 2019
41
2
4
Feb 2019
18
1
3
Mar 2019
41
3
4
Apr 2019
29
0
0
May 2019
26
6
2
Jun 2019
30
0
0
Jul 2019
39
4
3
Aug 2019
38
2
2
Sep 2019
32
2
2
Oct 2019
44
2
2
Nov 2019
14
0
0
Dec 2019
35
1
1
Jan 2020
33
2
3
Feb 2020
10
2
1
Mar 2020
25
2
1
Apr 2020
16
0
1
May 2020
25
2
0
Jun 2020
15
1
1
Jul 2020
22
1
1
Aug 2020
16
1
1
Sep 2020
37
1
1
Oct 2020
37
1
1
Nov 2020
26
1
1
Dec 2020
26
0
0
Jan 2021
31
2
0
Feb 2021
50
0
0
Mar 2021
30
1
0
Apr 2021
8
0
0
May 2021
8
2
2
Jun 2021
5
3
1
Jul 2021
1
0
0
Aug 2021
2
1
1
Sep 2021
3
2
1
Oct 2021
15
0
1
Nov 2021
50
4
2
Dec 2021
18
0
0
Jan 2022
22
0
0
Feb 2022
34
1
2
Mar 2022
34
0
0
Apr 2022
21
0
0
May 2022
43
1
2
Jun 2022
66
1
0
Jul 2022
25
0
0
Aug 2022
50
4
0
Sep 2022
52
4
0
Oct 2022
71
5
1
Nov 2022
26
2
0
Dec 2022
20
1
0
Jan 2023
8
2
1
Feb 2023
64
1
0
Mar 2023
18
1
1
Apr 2023
19
0
0
May 2023
36
2
0
Jun 2023
18
0
0
Jul 2023
12
1
0
Aug 2023
17
0
0
Sep 2023
22
2
0
Oct 2023
8
0
0
Nov 2023
38
3
1
Dec 2023
28
2
2
Jan 2024
25
1
2
Feb 2024
31
1
2
Mar 2024
24
0
0
Total
4805
715
707
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?